amorpha-4,11-diene

Amorpha-4,11-diene is a lipid of Prenol Lipids (PR) class. Amorpha-4,11-diene is associated with abnormalities such as abnormal fragmented structure. The associated genes with amorpha-4,11-diene are Synthetic Genes.

Cross Reference

Introduction

To understand associated biological information of amorpha-4,11-diene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with amorpha-4,11-diene?

amorpha-4,11-diene is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with amorpha-4,11-diene

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with amorpha-4,11-diene?

There are no associated biomedical information in the current reference collection.

What functions are associated with amorpha-4,11-diene?

There are no associated biomedical information in the current reference collection.

What lipids are associated with amorpha-4,11-diene?

There are no associated biomedical information in the current reference collection.

What genes are associated with amorpha-4,11-diene?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with amorpha-4,11-diene?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with amorpha-4,11-diene

Download all related citations
Per page 10 20 50 100 | Total 79
Authors Title Published Journal PubMed Link
Yuan J and Ching CB Dynamic control of ERG9 expression for improved amorpha-4,11-diene production in Saccharomyces cerevisiae. 2015 Microb. Cell Fact. pmid:25889168
Yuan J and Ching CB Combinatorial engineering of mevalonate pathway for improved amorpha-4,11-diene production in budding yeast. 2014 Biotechnol. Bioeng. pmid:24122315
Sun Z et al. Identification of novel knockout targets for improving terpenoids biosynthesis in Saccharomyces cerevisiae. 2014 PLoS ONE pmid:25386654
Komori A et al. Comparative functional analysis of CYP71AV1 natural variants reveals an important residue for the successive oxidation of amorpha-4,11-diene. 2013 FEBS Lett. pmid:23246612
Zhou K et al. Optimization of amorphadiene synthesis in bacillus subtilis via transcriptional, translational, and media modulation. 2013 Biotechnol. Bioeng. pmid:23483530
Zou R et al. Combinatorial engineering of 1-deoxy-D-xylulose 5-phosphate pathway using cross-lapping in vitro assembly (CLIVA) method. 2013 PLoS ONE pmid:24223968
Wang H et al. Trichome-specific expression of the amorpha-4,11-diene 12-hydroxylase (cyp71av1) gene, encoding a key enzyme of artemisinin biosynthesis in Artemisia annua, as reported by a promoter-GUS fusion. 2013 Plant Mol. Biol. pmid:23161198
Chen X et al. Statistical experimental design guided optimization of a one-pot biphasic multienzyme total synthesis of amorpha-4,11-diene. 2013 PLoS ONE pmid:24278153
Dahl RH et al. Engineering dynamic pathway regulation using stress-response promoters. 2013 Nat. Biotechnol. pmid:24142050
Shen J et al. Improvement of amorpha-4,11-diene production by a yeast-conform variant of Vitreoscilla hemoglobin. 2012 Mar-Apr Z. Naturforsch., C, J. Biosci. pmid:22624336
Shimane M et al. Mevalonate-dependent enzymatic synthesis of amorphadiene driven by an ATP-regeneration system using polyphosphate kinase. 2012 Biosci. Biotechnol. Biochem. pmid:22878192
Zheng Z et al. Engineering Escherichia coli for succinate production from hemicellulose via consolidated bioprocessing. 2012 Microb. Cell Fact. pmid:22455836
Westfall PJ et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22247290
Zhang Y et al. The production of artemisinin precursors in tobacco. 2011 Plant Biotechnol. J. pmid:20723135
Redding-Johanson AM et al. Targeted proteomics for metabolic pathway optimization: application to terpene production. 2011 Metab. Eng. pmid:21215324
Ma SM et al. Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. 2011 Metab. Eng. pmid:21810477
Wu T et al. [Biosynthesis of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli through introducing mevalonate pathway]. 2011 Sheng Wu Gong Cheng Xue Bao pmid:22016988
Olofsson L et al. Relative expression of genes of terpene metabolism in different tissues of Artemisia annua L. 2011 BMC Plant Biol. pmid:21388533
Sawai S and Saito K Triterpenoid biosynthesis and engineering in plants. 2011 Front Plant Sci pmid:22639586
Cankar K et al. A chicory cytochrome P450 mono-oxygenase CYP71AV8 for the oxidation of (+)-valencene. 2011 FEBS Lett. pmid:21115006
Peralta-Yahya PP et al. Identification and microbial production of a terpene-based advanced biofuel. 2011 Nat Commun pmid:21952217
Misawa N Carotenoid β-ring hydroxylase and ketolase from marine bacteria-promiscuous enzymes for synthesizing functional xanthophylls. 2011 Mar Drugs pmid:21673887
Wen W and Yu R Artemisinin biosynthesis and its regulatory enzymes: Progress and perspective. 2011 Pharmacogn Rev pmid:22279377
Farhi M et al. Generation of the potent anti-malarial drug artemisinin in tobacco. 2011 Nat. Biotechnol. pmid:22158354
Jang HJ et al. Retinoid production using metabolically engineered Escherichia coli with a two-phase culture system. 2011 Microb. Cell Fact. pmid:21801353
Guantai E and Chibale K How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials? 2011 Malar. J. pmid:21411013
Gao H et al. Engineering of a genome-reduced host: practical application of synthetic biology in the overproduction of desired secondary metabolites. 2010 Protein Cell pmid:21203934
Suthers PF et al. Improved computational performance of MFA using elementary metabolite units and flux coupling. 2010 Metab. Eng. pmid:19837183
Komatsu M et al. Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20133795
Arsenault PR et al. Reproductive development modulates gene expression and metabolite levels with possible feedback inhibition of artemisinin in Artemisia annua. 2010 Plant Physiol. pmid:20724645
Mannan A et al. Survey of artemisinin production by diverse Artemisia species in northern Pakistan. 2010 Malar. J. pmid:21047440
van Herpen TW et al. Nicotiana benthamiana as a production platform for artemisinin precursors. 2010 PLoS ONE pmid:21151979
Schramek N et al. Artemisinin biosynthesis in growing plants of Artemisia annua. A 13CO2 study. 2010 Phytochemistry pmid:19932496
Sleight SC et al. Designing and engineering evolutionary robust genetic circuits. 2010 J Biol Eng pmid:21040586
Dietrich JA et al. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). 2009 ACS Chem. Biol. pmid:19271725
Kong JQ et al. The improvement of amorpha-4,11-diene production by a yeast-conform variant. 2009 J. Appl. Microbiol. pmid:19191957
Kong JQ et al. [Production of amorpha-4,11-diene in engineered yeasts]. 2009 Yao Xue Xue Bao pmid:21355330
Anthony JR et al. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. 2009 Metab. Eng. pmid:18775787
Skerker JM et al. Evolution, ecology and the engineered organism: lessons for synthetic biology. 2009 Genome Biol. pmid:19941672
Tsuruta H et al. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. 2009 PLoS ONE pmid:19221601
Castaño-Cerezo S et al. An insight into the role of phosphotransacetylase (pta) and the acetate/acetyl-CoA node in Escherichia coli. 2009 Microb. Cell Fact. pmid:19852855
Michalodimitrakis K and Isalan M Engineering prokaryotic gene circuits. 2009 FEMS Microbiol. Rev. pmid:19016883
Ma D et al. Isolation and characterization of AaWRKY1, an Artemisia annua transcription factor that regulates the amorpha-4,11-diene synthase gene, a key gene of artemisinin biosynthesis. 2009 Plant Cell Physiol. pmid:19880398
Ro DK et al. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. 2008 BMC Biotechnol. pmid:18983675
Chang Y et al. Identification of optimal measurement sets for complete flux elucidation in metabolic flux analysis experiments. 2008 Biotechnol. Bioeng. pmid:18553391
Zhang Y et al. The molecular cloning of artemisinic aldehyde Delta11(13) reductase and its role in glandular trichome-dependent biosynthesis of artemisinin in Artemisia annua. 2008 J. Biol. Chem. pmid:18495659
Zeng Q et al. Production of artemisinin by genetically-modified microbes. 2008 Biotechnol. Lett. pmid:18008167
Huang B et al. Heterologous production of secondary metabolites as pharmaceuticals in Saccharomyces cerevisiae. 2008 Biotechnol. Lett. pmid:18512022
Pscheidt B and Glieder A Yeast cell factories for fine chemical and API production. 2008 Microb. Cell Fact. pmid:18684335
Suthers PF et al. Metabolic flux elucidation for large-scale models using 13C labeled isotopes. 2007 Sep-Nov Metab. Eng. pmid:17632026
Kong JQ et al. [Increase of copy number of HMG-CoA reductase and FPP synthase genes improves the amorpha4,11-diene production in engineered yeast]. 2007 Yao Xue Xue Bao pmid:18338647
Covello PS et al. Functional genomics and the biosynthesis of artemisinin. 2007 Phytochemistry pmid:17399751
Julsing MK et al. Functional analysis of genes involved in the biosynthesis of isoprene in Bacillus subtilis. 2007 Appl. Microbiol. Biotechnol. pmid:17458547
Serrano L Synthetic biology: promises and challenges. 2007 Mol. Syst. Biol. pmid:18091727
Teoh KH et al. Artemisia annua L. (Asteraceae) trichome-specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin. 2006 FEBS Lett. pmid:16458889
Newman JD et al. High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. 2006 Biotechnol. Bioeng. pmid:16878333
Lindahl AL et al. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. 2006 Biotechnol. Lett. pmid:16614895
Kim SH et al. Cyclization mechanism of amorpha-4,11-diene synthase, a key enzyme in artemisinin biosynthesis. 2006 J. Nat. Prod. pmid:16724836
Picaud S et al. Amorpha-4,11-diene synthase: mechanism and stereochemistry of the enzymatic cyclization of farnesyl diphosphate. 2006 Arch. Biochem. Biophys. pmid:16143293
Ro DK et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. 2006 Nature pmid:16612385
Wu S et al. Redirection of cytosolic or plastidic isoprenoid precursors elevates terpene production in plants. 2006 Nat. Biotechnol. pmid:17057703
Wallaart TE et al. Amorpha-4,11-diene synthase: cloning and functional expression of a key enzyme in the biosynthetic pathway of the novel antimalarial drug artemisinin. 2001 Planta pmid:11289612
pmid:
pmid:19664791
pmid:27933789
pmid:17438551
pmid:27273626
pmid:27930305
pmid:28520394
pmid:22565787
pmid:18651187
pmid:15797234
pmid:28526743
pmid:26804325
pmid:25715782
pmid:25058645
pmid:27673334
pmid:15678372
pmid:18203058